Administration of pro re nata medications by the nurse to incapacitated patients: An ethical perspective

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10045/116822
Información del item - Informació de l'item - Item information
Título: Administration of pro re nata medications by the nurse to incapacitated patients: An ethical perspective
Autor/es: Vaismoradi, Mojtaba | Moe, Cathrine Fredriksen | Vizcaya-Moreno, M. Flores | Paal, Piret
Grupo/s de investigación o GITE: Enfermería Clínica (EC)
Centro, Departamento o Servicio: Universidad de Alicante. Departamento de Enfermería
Palabras clave: Ethics | Nurse | Harm | Medicines management | Patient safety | Pro re nata
Área/s de conocimiento: Enfermería
Fecha de publicación: 23-jul-2021
Editor: SAGE Publications
Cita bibliográfica: Clinical Ethics. 2022, 17(1): 5-13. https://doi.org/10.1177/14777509211034146
Resumen: The administration of pro re nata medications is the responsibility of the nurse. However, ethical uncertainties often happen due to the inability of incapacitated patients to collaborate with the nurse in the process of decision making for pro re nata medication administration. There is a lack of integrative knowledge and insufficient understanding regarding ethical considerations surrounding the administration of pro re nata medications to incapacitated patients. Therefore, they have been discussed in this paper and practical strategies to avoid unethical practices have been suggested. The complicated caring situation surrounding the administration of pro re nata medications is intertwined with ethical issues affecting the consideration of the patient's wishes and interventions that override them. The patient's right of autonomy and treatment refusal, surrogacy role, paternalism, and coercion are the main ethos of ethical pro re nata medication administration. Education and training can help nurses avoid legal and ethical issues in pro re nata medicines management and improve the quality and safety of healthcare. Empirical research is needed to improve our understanding of this phenomenon in the multidisciplinary environment of medicines management.
URI: http://hdl.handle.net/10045/116822
ISSN: 1477-7509 (Print) | 1758-101X (Online)
DOI: 10.1177/14777509211034146
Idioma: eng
Tipo: info:eu-repo/semantics/article
Derechos: © The Author(s) 2021
Revisión científica: si
Versión del editor: https://doi.org/10.1177/14777509211034146
Aparece en las colecciones:INV - Enfermería Clínica - Artículos de Revistas

Archivos en este ítem:
Archivos en este ítem:
Archivo Descripción TamañoFormato 
ThumbnailVaismoradi_etal_2021_ClinEthics_final.pdfVersión final (acceso restringido)924,69 kBAdobe PDFAbrir    Solicitar una copia
ThumbnailVaismoradi_etal_2021_ClinEthics_accepted.pdfAccepted Manuscript (acceso abierto)263,54 kBAdobe PDFAbrir Vista previa


Todos los documentos en RUA están protegidos por derechos de autor. Algunos derechos reservados.